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Abstract
Background: NPC1L1 is the molecular target of the cholesterol lowering drug Ezetimibe and mediates the intestinal
absorption of cholesterol. Inhibition or deletion of NPC1L1 reduces intestinal cholesterol absorption, resulting in reduction
of plasma cholesterol levels.
Principal Findings: Here we present the 2.8 A ˚ crystal structure of the N-terminal domain (NTD) of NPC1L1 in the absence of
cholesterol. The structure, combined with biochemical data, reveals the mechanism of cholesterol selectivity of NPC1L1.
Comparison to the cholesterol free and bound structures of NPC1(NTD) reveals that NPC1L1(NTD) is in a closed
conformation and the sterol binding pocket is occluded from solvent.
Conclusion: The structure of NPC1L1(NTD) reveals a degree of flexibility surrounding the entrance to the sterol binding
pocket, suggesting a gating mechanism that relies on multiple movements around the entrance to the sterol binding
pocket.
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Introduction
Cholesterol is an essential element of cell membranes, required
for proper permeability and structural integrity. The proper
regulation of cholesterols levels is critical for human health and
individuals with elevated cholesterol levels have increased risks for
coronary heart disease. Cholesterol also serves as an important
signaling molecule, is the subject of feedback regulation, and serves
as the precursor for steroid hormones. In humans, pathways
including de novo synthesis, biliary excretion, and intestinal
absorption maintain cholesterol homeostasis.
Dietary cholesterol is primarily absorbed in the intestine. After
digestion in the lumen and hydrolysis of dietary lipids, cholesterol is
solubilizedinmixedmicellescontainingbile acid and phospholipids.
This solubilization facilitates the movement of cholesterol from the
bulk phase of the lumen to the surface of the enterocyte. Cholesterol
absorption within enterocytes is mediated by Niemann-Pick C1
Like 1 (NPC1L1), a protein primarily expressed in the intestine [1]
and the target of the cholesterol absorption inhibitor Ezetimibe [2].
NPC1L1 is a polytopic membrane protein that contains two
conserved domains: the sterol sensing domain and the NPC1
domain. The NPC1 domain resides in the amino-terminal
extracellular loop and is highly conserved in all NPC1 homologues.
Within the liver, cholesterol is secreted along with bile acids. In
humans, NPC1L1 is also expressed in the liver. While the exact
function of hepatic NPC1L1 is unknown, overexpression of
NPC1L1 in livers of transgenic mice results in increased biliary
reabsorption of cholesterol and increased plasma cholesterol [3]. A
major source of cholesterol excretion in the liver is the ATP-
binding cassette transporter ABCG5/G8 [4], which is also
responsible for phytosterol excretion and NPC1L1 may play a
role in fine tuning total cholesterol excretion in conjunction with
ABCG5/G8.
Reduction or inhibition of NPC1L1 lowers intestinal cholesterol
absorption by ,70% emphasizing its key role in dietary cho-
lesterol absorption. In transgenic mice, the effects of overexpres-
sion of NPC1L1 in the liver can be reversed by inhibition with
Ezetimibe, reducing plasma cholesterol levels to normal. Thus,
NPC1L1 is a proven target for lowering cholesterol from both
dietary absorption and hepatic reabsorption.
Recently NPC1L1 has been shown to translocate between the
plasma membrane and the endocytic recycling compartment in a
cholesterol dependent manner. This translocation of NPC1L1 is
blocked by Ezetimibe, and is specific for cholesterol over
phytosterols [5,6]. While phytosterol absorption has been shown
to be NPC1L1 dependant [7], its absorption rate is lower than
cholesterol and is inversely proportional to the size of the sterol,
cholesterol . campesterol . b-sitosterol [8].
The mechanism through which NPC1L1 mediates cholesterol
transport is unknown. NPC1L1 hashigh sequencehomology (,40%)
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cholesterol out of lysosomes for subsequent delivery to the
endoplasmic reticulum and plasma membrane. NPC1 functions in
tandem with NPC2, a soluble lysosomal protein, to move unesterified
cholesterol [9]. Current models predict that NPC2 binds to
unesterified cholesterol and delivers it to NPC1 for subsequent egress
out of the lysosome. Cholesterol is virtually insoluble and NPC2 acts
to solubilize cholesterol, allowing for transport in aqueous environ-
ments. While NPC2 works in conjunction with NPC1, NPC2 is not
required for the function of NPC1L1 and mice lacking NPC2 absorb
cholesterol normally [10]. While a protein partner for NPC1L1 has
not been identified, it has been shown that cholesterol absorption by
NPC1L1 in a cell culture model is dependent on the concentration of
bile salt used to solubilize cholesterol in mixed micelles [11,12]. Bile
salt mixed micelles may serve an analogous function to NPC2,
acting as a solubilizing agent to allow transport of cholesterol in
aqueous environments and prevent precipitation/crystallization of
cholesterol.
Figure 1. Sterol Binding and Specificity of NPC1L1(NTD). (A) Cholesterol binding. Each reaction, in a final volume of 100 ml, contained
0.5 pmol of purified HIS6-NPC1L1(NTD) and the indicated concentration of
3H-cholesterol in the absence (N) or presence (#) of 100 uM unlabeled
cholesterol. Bound
3H-cholesterol was measured as described in Materials and Methods. Each data point represents the average of triplicate assays. (B)
Competitive binding of
3H-cholesterol in the presence of unlabeled sterols. Each reaction, in a total volume of 100 ml, contained 0.5 pmol HIS6-
NPC1L1(NTD), 10 nM
3H-cholesterol and 1 mM of the indicated unlabeled sterol. Each data point represents the average of triplicate assays and
represents the amount of
3H-cholesterol bound relative to that in the control tube, which did not contain unlabeled sterol. (C) Competitive binding of
3H-cholesterol in the presence of unlabeled sterols. Each reaction, in a total volume of 100 ml, contained 0.5 pmol HIS6-NPC1L1(NTD), 10 nM
3H-
cholesterol and varying concentrations of the indicated unlabeled sterol. Each data point represents the average of triplicate assays and represents
the amount of
3H-cholesterol bound relative to that in the control tube, which did not contain unlabeled sterol.
doi:10.1371/journal.pone.0018722.g001
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both cholesterol bound and free forms. The structure of apo-
NPC1(NTD) was nearly identical to that of cholesterol bound
NPC1(NTD) and revealed a cholesterol binding pocket that was
open to solvent. In the current study, we have determined the
crystal structure of NPC1L1(NTD) to 2.8 A ˚ resolution in a
cholesterol free, closed form. The structure of NPC1L1(NTD),
while sharing the same overall topology as NPC1(NTD), reveals a
cholesterol binding pocket that is closed from solvent, suggesting
a gating mechanism that relies on the movement of multiple
elements around the cholesterol entrance. The cholesterol
binding pocket is slightly larger than that of NPC1(NTD),
suggesting broader sterol specificity. In vitro biochemical mea-
surements of cholesterol binding and competition studies confirm
this prediction.
Results
A recombinant form of human NPC1L1(NTD) spanning
residues 22–284 was produced in High-5 cells using a baculovirus
vector. The soluble, secreted protein was purified from the culture
media and the identity of the protein was confirmed by western
blot analysis and N-terminal sequencing (data now shown).
According to size exclusion chromatography, NPC1L1(NTD)
exists as a monomer in solution (data not shown).
Cholesterol binding specificity of NPC1L1(NTD)
To assay cholesterol binding to NPC1L1(NTD), we utilized an
assay previously developed for monitoring cholesterol binding to
SCAP [13].
3H-cholesterol was incubated with His-tagged
NPC1L1(NTD) and the protein was applied to a nickel-agarose
column. Protein bound
3H-cholesterol was eluted and quantified
by scintillation counting (Fig 1A). Binding of
3H-cholesterol was
saturable with a Kd,1264 nM. At saturation 0.5 pmol of
NPC1L1(NTD) bound to ,0.4860.04 pmol of cholesterol
suggesting a stoichiometry of one molecule of cholesterol for each
NPC1L1(NTD) molecule.
We then carried out competitive binding studies to determine
the specificity of various sterols toward NPC1L1(NTD). Various
concentrations of unlabeled sterols were incubated with a fixed
concentration of
3H-cholesterol and NPC1L1(NTD) and the
ability of the unlabelled sterols to compete for binding was
determined (Fig. 1B,C). Cholesterol, desmosterol, and lanosterol
were equally effective in competing for cholesterol binding to
NPC1L1(NTD), while 25-hydroxycholesterol (25HC) was slightly
better. Epi-cholesterol and b-sitosterol were much less effective in
competing for cholesterol binding to NPC1L1(NTD).
Structure of NPC1L1(NTD)
The structure of NPC1L1(NTD) in the absence of cholesterol
was determined by molecular replacement and refined to 2.83A ˚
(Table 1). The model spans residues 22–265. Residues 266–284
were poorly ordered and were not placed in the electron density.
NPC1L1(NTD) is mainly helical, composed of nine a-helices,
flanked by a mixed three strand b-sheet (Fig 2A). Electron density
is present for N-acetyl glucosamine attached to ASN55 and
ASN138. The structure can be divided into 2 domains, residues
22–242 (domain A), and residues 243–265 (domain B). Nine
conserved disulfide bonds constrain the structure of
NPC1L1(NTD), with Domain A containing six and Domain B
containing two disulfide bonds. An interdomain disulfide
(CYS113:CYS254) provides a second linkage between Domain
A and B. A large central cavity, formed by helices a2,a3,a4,a7,
and a8 is visible within NPC1L1(NTD) (Fig 3A,C). The cavity,
while large enough to accommodate the tetracyclic ring of
cholesterol, narrows as it reaches the surface, closing to a width
of ,2.3A ˚.
Comparison of NPC1L1 and NPC1
The structure of NPC1L1(NTD) is nearly identical to
NPC1(NTD) with a rmsd across equivalent Ca atoms of 1.6A ˚
(Fig. 2B). Helices 4, 6, and 8 are most similar between the proteins,
with a rmsd across Ca atoms of 0.7A ˚ and are spatially constrained
by a disulfide bond between CYS116 and CYS172. Differences
occur between the two proteins in regions around the entrance of
the cholesterol binding pocket (Fig 2B, 3). The largest differences
occurring in a3, a7, and the a8/b7 loop. Rotation of a3 and a7i n
NPC1L1(NTD) relative to NPC1(NTD) results in a narrowing of
the entrance to the sterol binding pocket. The most significant
changes are in the a8/b7 loop, where LEU213 (GLN200 in
NPC1) is rotated toward a7 displacing ASN211 (ASN198 in
NPC1) which forms a hydrogen bond with ASP208 (Fig 4A). In
NPC1(NTD), ASN198 forms a hydrogen bond with the main
chain amine of GLN200, resulting in a shift of the a8/b7 loop and
GLN200 away from a7 (Fig 4B). These differences result in a
larger entrance to the sterol binding pocket in NPC1(NTD), with a
width of ,4.8A ˚.
Discussion
Based upon the high sequence conservation (,33% identity), it
was expected that the overall fold of NPC1L1(NTD) would be
similar to NPC1(NTD). The conformation of apo-NPC1L1(NTD)
observed in the present work, however, reveals a closed
conformation. Previously, we observed that apo-NPC1(NTD)
was in an identical conformation as the cholesterol bound form
and the cholesterol binding pocket was open to solvent [9]. As the
cholesterol bound and unbound forms of NPC1(NTD) crystallized
in the same spacegroup, the conformation of apo-NPC1(NTD)
observed in our previous study may have been the result of crystal
packing. Comparison of apo-NPC1L1(NTD) to the sterol bound
Table 1. Data collection and refinement statistics.
Space Group C2221
a, A ˚ 73.235
b, A ˚ 107.133
c, A ˚ 68.718
Resolution, A ˚ (final shell) 50-2.83 (2.90-2.83)
Reflections
Total 25279
Unique 6148
Completeness, % 92.3 (83.0)
Rsym, % 9.4 (25.7)
Model Refinement Statistics
Resolution, A ˚ (final shell) 30-2.83 (2.91-2.83)
Rwork, % 22.6 (25.1)
Rfree, % 29.0 (42.1)
Rms deviations from target values
Bond lengths, A ˚ 0.006
Bond angles, u 1.027
doi:10.1371/journal.pone.0018722.t001
NPC1L1 Structure
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e18722Figure 2. The Structure of NPC1L1(NTD). (A) NPC1L1(NTD) is represented as a ribbon diagram and the disulfide bonds are shown in yellow.
Domain A is colored orange (a-helices), cyan (b-sheets), and gray (loops). a3 (red), a7 (blue), and the a8/b7 loop (green) surround the entrance of the
cholesterol binding pocket. Domain B is colored magenta. (B) Superposition of NPC1L1(NTD) (yellow) and NPC1(NTD) (gray). Bound cholesterol in
NPC1 is shown as a stick model. Regions around the entrance of the cholesterol binding pocket in NPC1L1 are colored red (a3), blue (a7), and green
(a8/b7 loop). (C) Sequence alignment of NPC1L1(NTD) and NPC1(NTD). N-linked glycosylation sites are shaded gray. Residues lining the cholesterol
binding pocket are shaded yellow in NPC1. In NPC1L1, residues within the interior of the closed cholesterol binding pocket are shaded blue, residues
on the exterior of the closed cholesterol binding pocket are shaded green, and residues separating the interior from the exterior are shaded red.
Regions around the entrance to the cholesterol binding pocket that change conformation are boxed. The secondary structure of NPC1L1(NTD) is
shown below the sequence.
doi:10.1371/journal.pone.0018722.g002
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movements around the entrance to the sterol binding pocket are
required to expand the entrance and allow entry of cholesterol.
The structure of NPC1L1(NTD) and the biochemical data
presented here are consistent with in vitro cell culture assays
demonstrating a high degree of specificity for cholesterol over
other sterols. The structure of NPC1L1(NTD) reveals a slightly
larger binding pocket than is present in NPC1(NTD) allowing for
broader sterol specificity than NPC1 [14,15], in particular sterols
with substitutions at C4 (Fig. 4C). Residues near the C4 position
are smaller in NPC1L1 (PHE35 and LEU216) compared to
NPC1 (TRP27 and PHE203), increasing the size of the sterol
binding pocket and accommodating C4 substituted sterols such
as lanosterol. The contribution of NPC1L1 to the absorption of
C4 substituted sterols has not been defined and further
experiments will be required to determine what role it may
have in the absorption of this class of sterols. While the residues
near the C4 position are smaller in NPC1L1 compared to
NPC1, residues around the isooctyl sidechain are roughly
equivalent. The addition of an ethyl group at C24 on b-
sitosterol would result in an unfavorable steric clash and we were
unable to observe significant competitive binding of b-sitosterol
to NPC1L1(NTD).
Ge et. al. [5] reported that cholesterol specifically promotes
internalization of NPC1L1, whereas b-sitosterol and other sterols
with substitutions at C24 had little effect on internalization of
NPC1L1. This internalization was blocked by Ezetimibe, which
has been shown to require the 2
nd extracellular domain of
NPC1L1 for high affinity binding [16]. This result is surprising,
given in vivo work in mice showing that NPC1L1 mediates
phytosterol absorption [7]. Further experiments will be needed to
address the mechanism of cholesterol transport by NPC1L1 and
the functions of the different domains in cholesterol binding,
transport and internalization.
Figure 3. NPC1L1(NTD) in a closed conformation. (A) The surface of NPC1L1(NTD), colored green, reveals a cholesterol binding pocket (blue)
that is closed to solvent. (B) The surface of NPC1(NTD), colored gray, shows the cholesterol binding pocket (yellow) exposed to solvent. The isooctyl
side chain of cholesterol (stick model in green) is visible and solvent exposed. (C) Cutaway view of the cholesterol binding pocket of NPC1L1(NTD) in
the closed conformation. (D) Cutaway view of the cholesterol binding pocket of NPC1(NTD) in an open conformation.
doi:10.1371/journal.pone.0018722.g003
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Materials and Plasmids
3H-cholesterol was obtained from American Radiolabeled
Chemicals; all other sterols were from Steraloids.
We generated a recombinant baculovirus encoding the N-
terminal domain of human NPC1L1 by amplifying residues 22–
284 of human NPC1L1 by PCR. The PCR fragment was digested
with Sfo1 and EcoR1 and ligated into a modified version of
pFastBacHTa (Invitrogen) that contains the honeybee mellitin
signal sequence preceding a HIS6-tag [9].
Sterol Binding
Each reaction contained, in a final volume of 100 ml of Buffer A
(25 mM Tris pH 7.5, 150 mM NaCl) containing 0.0005% (v/v)
NP-40), varying concentrations of the indicated sterols and
0.5 pmol of NPC1L1(NTD). After incubation for 24 hr at 4uC,
each assay mixture was loaded onto a 2-ml column packed with
0.2 ml of Ni-NTA-agarose beads that had been pre-equilibrated
with buffer A containing 0.0015% (v/v) NP-40 and then washed
with 10 ml of buffer A containing 0.0015% (v/v) NP-40. Protein-
bound
3H-cholesterol was eluted with 1.2 ml of buffer A
containing 0.0015% (v/v) NP-40 and 250 mM imidazole and
quantified by scintillation counting.
Protein Expression and Purification
Sf9 cells infected with NPC1L1(NTD) baculovirus [17] were
used to infect High-5 cells (Invitrogen) at 1610
6 cells/ml in
Excel-405 medium. After incubation for 96 hr at 27uC, cells
were pelleted by centrifugation, and the medium was concen-
trated by tangential flow filtration. NPC1L1(NTD) was purified
from the concentrated medium by Ni-NTA chromatography.
NPC1L1(NTD) was further purified by ion exchange chroma-
tography followed by size exclusion chromatography. For
crystallization the HIS6-tag was removed by tobacco etch virus
protease cleavage prior to ion exchange chromatography.
Crystallization and Structure Determination
Initial crystals were obtained using the Fluidigm TOPAZ
system. Crystals of NPC1L1(NTD) were produced by mixing
protein at 15 mg/ml with an equal volume of reservoir solution
containing 0.9 M Li2SO4 and 100 mM MES pH 6.5. Crystals
were transferred stepwise into reservoir solution containing 25%
(v/v) glycerol and flash-frozen in a 2160uC nitrogen stream. The
crystals belong to space group C2221. Diffraction data were
collected at the Advanced Photon Source (Argonne, IL, USA)
beam line 19-ID and processed with HKL2000 [18] and the
CCP4 suite [19]. The structure was determined by molecular
replacement using the program PHASER [20]. The apo structure
of NPC1(NTD) was used as the search model (Protein Data Bank
ID code 3GKH). The model was built with the program COOT
[21]. Initial refinement was performed with CNS [22], and the
final cycles of refinement were performed with REFMAC [23].
Figures were generated with PYMOL (http://www.pymol.org).
Accession Codes
The atomic coordinates have been deposited in the Protein
Data Bank, www.pdb.org (PDB ID code 3QNT).
Acknowledgments
We thank Chad Brautigam and Diana Tomchick for assistance with data
collection and members of the J.D. laboratory for assistance during the
course of this project.
Author Contributions
Conceived and designed the experiments: HJK. Performed the experi-
ments: HJK MP. Analyzed the data: HJK. Contributed reagents/
materials/analysis tools: HJK. Wrote the paper: HJK JD.
References
1. Altmann SW, Davis HR, Jr., Zhu LJ, Yao X, Hoos LM, et al. (2004) Niemann-
Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science
303: 1201–1204.
2. Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, et al. (2005) The
target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad
Sci U S A 102: 8132–8137.
3. Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, et al. (2007) Hepatic
Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a
target of ezetimibe. J Clin Invest 117: 1968–1978.
4. Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, et al. (2002)
Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary
cholesterol secretion. Proc Natl Acad Sci U S A 99: 16237–16242.
Figure 4. Structural differences between NPC1L1 and NPC1. (A) In the closed form of NPC1L1(NTD), ASN211 forms a hydrogen bond with
ASP208, allowing LEU213 to rotate toward a7. (B) In the cholesterol bound form of NPC1(NTD), ASN198 forms a hydrogen bond with the main chain
amine of GLN200, which is rotated away from a7. (C) Superposition of NPC1L1(NTD) (yellow) and NPC1(NTD) (gray) within the cholesterol binding
pocket. The smaller residues of NPC1L1, PHE35 and LEU216, expand the cholesterol binding pocket, accommodating sterols such as lanosterol.
doi:10.1371/journal.pone.0018722.g004
NPC1L1 Structure
PLoS ONE | www.plosone.org 6 April 2011 | Volume 6 | Issue 4 | e187225. Ge L, Wang J, Qi W, Miao HH, Cao J, et al. (2008) The cholesterol absorption
inhibitor ezetimibe acts by blocking the sterol-induced internalization of
NPC1L1. Cell Metab 7: 508–519.
6. Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, et al. (2006) Cholesterol-regulated
translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake.
J Biol Chem 281: 6616–6624.
7. Davis HR, Jr., Zhu LJ, Hoos LM, Tetzloff G, Maguire M, et al. (2004)
Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol
transporter and a key modulator of whole-body cholesterol homeostasis. J Biol
Chem 279: 33586–33592.
8. Lutjohann D, Bjorkhem I, Beil UF, von Bergmann K (1995) Sterol absorption
and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols:
effect of sitostanol treatment. J Lipid Res 36: 1763–1773.
9. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, et al. (2009)
Structure of N-terminal domain of NPC1 reveals distinct subdomains for
binding and transfer of cholesterol. Cell 137: 1213–1224.
10. Dixit SS, Sleat DE, Stock AM, Lobel P (2007) Do mammalian NPC1 and NPC2
play a role in intestinal cholesterol absorption? Biochem J 408: 1–5.
11. Haikal Z, Play B, Landrier JF, Giraud A, Ghiringhelli O, et al. (2008) NPC1L1
and SR-BI are involved in intestinal cholesterol absorption from small-size lipid
donors. Lipids 43: 401–408.
12. Yamanashi Y, Takada T, Suzuki H (2007) Niemann-Pick C1-like 1
overexpression facilitates ezetimibe-sensitive cholesterol and beta-sitosterol
uptake in CaCo-2 cells. J Pharmacol Exp Ther 320: 559–564.
13. Radhakrishnan A, Sun LP, Kwon HJ, Brown MS, Goldstein JL (2004) Direct
binding of cholesterol to the purified membrane region of SCAP: mechanism for
a sterol-sensing domain. Mol Cell 15: 259–268.
14. Infante RE, Radhakrishnan A, Abi-Mosleh L, Kinch LN, Wang ML, et al.
(2008) Purified NPC1 protein: II. Localization of sterol binding to a 240-amino
acid soluble luminal loop. J Biol Chem 283: 1064–1075.
15. Infante RE, Abi-Mosleh L, Radhakrishnan A, Dale JD, Brown MS, et al. (2008)
Purified NPC1 protein. I. Binding of cholesterol and oxysterols to a 1278-amino
acid membrane protein. J Biol Chem 283: 1052–1063.
16. Weinglass AB, Kohler M, Schulte U, Liu J, Nketiah EO, et al. (2008)
Extracellular loop C of NPC1L1 is important for binding to ezetimibe. Proc Natl
Acad Sci U S A 105: 11140–11145.
17. Wasilko DJ, Lee SE (2006) TIPS: Titerless infected-cells preservation and scale-
up. Bioprocessing Journal 5: 29–32.
18. Otwinowski Z, Minor W (1997) Processing of x-ray diffraction data collected in
oscillation mode. Methods in Enzymology 276: 307–326.
19. Collaborative Computational Project 4 (1994) The CCP4 suite: programs for
protein crystallography. Acta Crystallogr D Biol Crystallogr 50: 760–763.
20. Storoni LC, McCoy AJ, Read RJ (2004) Likelihood-enhanced fast rotation
functions. Acta Crystallogr D Biol Crystallogr 60: 432–438.
21. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
22. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, et al. (1998)
Crystallography & NMR system: A new software suite for macromolecular
structure determination. Acta Crystallogr D Biol Crystallogr 54: 905–921.
23. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular
structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystal-
logr 53: 240–255.
NPC1L1 Structure
PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e18722